Online inquiry

IVTScrip™ mRNA-Human ABCA13, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12329MR)

This product GTTS-WK12329MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABCA13 protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_152701.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 154664
UniProt ID Q86UQ4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABCA13, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12329MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK12013MR IVTScrip™ mRNA-Human AAGAB, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AAGAB
GTTS-WK6439MR IVTScrip™ mRNA-Human CRIP1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA CRIP1
GTTS-WK15786MR IVTScrip™ mRNA-Human ANK3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANK3
GTTS-WK19385MR IVTScrip™ mRNA-Human ANK2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANK2
GTTS-WK9347MR IVTScrip™ mRNA-Human ABCC3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ABCC3
GTTS-WK20275MR IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Androgen-binding protein
GTTS-WK2420MR IVTScrip™ mRNA-Human Aquaporin-0, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Aquaporin-0
GTTS-WK26734MR IVTScrip™ mRNA-Human APOL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA APOL2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW